Lv1
40 积分 2024-10-23 加入
The Nephrotoxicity of Checkpoint Inhibitors: A Mini Review
22天前
已完结
The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer
1个月前
已完结
Lines of Therapy for Locally Advanced/Metastatic Urothelial Carcinoma: The New Paradigm
2个月前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
2个月前
已完结
Efficacy, safety, and biomarker analysis of neoadjuvant avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy (NeoAvAx)
3个月前
已关闭
Anlotinib-Induced Hypertension: Current Concepts and Future Prospects
3个月前
已完结
Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1
6个月前
已完结
In Vitro Kinetic Characterization of Axitinib Metabolism
6个月前
已完结
Exploration of the mechanism of anlotinib in reversing PD-1 immunotherapy resistance: insights from single-cell sequencing
7个月前
已完结
311eP Exploration of the mechanism of anlotinib in reversing PD-1 immunotherapy resistance: Insights from single-cell sequencing
7个月前
已关闭
皖公网安备34019202002308
